Sort
82,697 grants matching “vaccine development”
Using immune complex vaccines to optimize antibody responses to HIV Env
$875,894Catarina E Hioe · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AI
Improving the safety profile of DNA prime - protein boost HIV vaccinations
$875,648Egil Lien · Univ Of Massachusetts Med Sch Worcester · U19 · FY2010 · AI
Innate and Adaptive Immune Responses to Lymph-Borne Infections
$875,624Ulrich H Von Andrian · Harvard Medical School · P01 · FY2012 · AI
JHU-MCAIDS HPTN TRIAL SITE-CHINA
$875,513Johns Hopkins University · U01 · FY2003 · AI
TASK A04: EVALUATION OF THERAPEUTICS AND VACCINES IN MOUSE MODELS OF DENGUE VIRUS
$875,449David Beasley · University Of Texas Med Br Galveston · N01 · FY2018 · AI
Clinical Program in Pediatric Sarcomas
$875,448Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Project 1: Pharmacokinetics of Combination Antiretroviral Intravaginal Rings
$875,428Craig Walter Hendrix · Oak Crest Institute Of Science · U19 · FY2017 · AI
Forward Genetic Analysis of Innate Immune Signaling
$875,418Bruce A Beutler · Scripps Research Institute, The · U19 · FY2015 · AI
Biomaterials for Targeted Modulation of Conventional Type 1 Dendritic Cells
$875,408Hua Wang · University Of Illinois At Urbana-Champaign · R01 · FY2025 · CA
Optimizing Antibody Vaccines Against HIV
$875,378William Schief · Massachusetts General Hospital · P01 · FY2014 · AI
Synthetic Vaccine Against Human Pathogenic Bacteria
$875,301Vince Pozsgay · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Papillomavirus Virion Proteins and Vaccines
$875,282Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Trial for Influenza Vaccine
$875,247Clarence Buddy Creech · Vanderbilt University Medical Center · N01 · FY2019 · AI
A Rapid Portable HIV Detection and Monitoring System for Low Resource Settings
$875,245Robert Juncosa · Thermal Gradient, Inc. · R44 · FY2014 · AI
Approaches to Improve the Efficacy of Prime-boost Immunization against HIV/AIDS
$875,225Shiu-Lok Hu · University Of Washington · R01 · FY2018 · AI
A San Francisco Street Youth Cohort: At Risk and HIV+
$875,049Anna-Barbara None Moscicki · University Of California, San Francisco · U01 · FY2009 · HD
Dengue Reporter Virus Neutralization Assay for Clinical Studies
$875,007Eva Harris · Integral Molecular · R42 · FY2009 · AI
Fogarty AIDS International Training &Research Program *
$875,000Johns Hopkins University · D43 · FY2004 · TW
Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) - 2022
$875,000Didine Kinkodi Kaba · Kinshasa School Of Public Health · U01 · FY2022 · CK
Dissecting the host-plasmid interplay to unravel the spread of ESBL-producing K. pneumoniae
$874,998Barry Neal Kreiswirth · Hackensack University Medical Center · U01 · FY2025 · AI
THE TEDDY STUDY - COLORADO CLINICAL CENTER
$874,815Marian J. Rewers · University Of Colorado Denver · U01 · FY2009 · DK
Malaria Drug Resistance and Disease Virulence
$874,777Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Serologic and Molecular Studies of human anti-hCoV antibody cross-immunity and protective responses among endemic HCoVs and SARS-CoV2
$874,734Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2023 · AI
Boston Pediatric AIDS Clinical Trials Unit
$874,670Kenneth J McIntosh · Boston Children'S Hospital · U01 · FY2007 · AI
Approaches to Improve the Efficacy of Prime-boost Immunization against HIV/AIDS
$874,640Shiu-Lok Hu · University Of Washington · R01 · FY2017 · AI